Trial Search Results
PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation Clinical Study
The purpose of this extended study is to evaluate the safety and effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation in combination with the commercially available Atrium iCAST™ covered stent in patients in a treatment of aortoiliac and iliac aneurysms.
Stanford is currently not accepting patients for this trial.
Lead Sponsor:
Cook Research Incorporated
Stanford Investigator(s):
Intervention(s):
- Device: Zenith® Branch Endovascular Graft-Iliac Bifurcation,
- Device: Atrium iCAST™
- Device: Zenith® Flex AAA Endovascular Graft
Phase:
N/A
Eligibility
Inclusion Criteria:
- An aortioiliac or iliac aneurysm
- An unsuitable distal sealing site for a traditional Zenith iliac leg graft within the
common lilac artery
Exclusion Criteria:
- Less than 18 years of age
- Inability or refusal to give informed consent
- Disease considerations that would compromise patient safety or study outcomes
- Pregnant, breast-feeding or planning on becoming pregnant prior to completion of the
study
- Unwilling or unable to comply with the follow-up schedule
- Simultaneously participating in another investigative device or drug study
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Not Recruiting